Core Insights - Axon Enterprise, Inc. reported third-quarter 2025 adjusted earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.63, with a year-over-year decrease of 19.3% due to rising operating costs and expenses [1][6] Revenue Performance - Total revenues reached $710.6 million, exceeding the consensus estimate of $700 million, and reflecting a 31% year-over-year increase driven by strong demand for TASER 10, Axon Body 4, and counter-drone equipment, along with growing adoption of premium software solutions [2] Business Segment Performance - Connected Devices: Revenues increased by 23.6% year over year to $405.4 million, driven by demand for TASER 10 devices and Axon Body 4, although adjusted gross margin decreased to 52.1% from 54.5% [4] - Software & Services: Revenues surged 41.1% year over year to $305.2 million, supported by an increase in users and premium software adoption, with adjusted gross margin improving to 76.8% from 76.3% [5] Margin Profile - Cost of sales rose 32.7% year over year to $283.3 million, while total operating expenses climbed 40% to $429.5 million, leading to a decrease in adjusted gross margin to 62.7% from 63.2% [6] Balance Sheet & Cash Flow - At the end of Q3 2025, cash and cash equivalents stood at $1.42 billion, a significant increase from $454.8 million at the end of 2024. However, net cash used from operating activities was $5.9 million compared to $158.1 million generated in the previous year [7] - Adjusted free cash flow was negative $71.4 million in the first nine months of 2025, down from $117.5 million in the prior-year period [8] Outlook - For Q4 2025, Axon anticipates revenues between $750 million and $755 million, indicating a 31% increase at the midpoint, with projected adjusted EBITDA of $178-$182 million [9] - For the full year 2025, revenues are expected to be around $2.74 billion, reflecting approximately 31% year-over-year growth, with an adjusted EBITDA margin of about 25% [11] Major Developments - Axon signed a definitive agreement to acquire Carbyne for $625 million, expected to close in Q1 2026, pending customary closing conditions [13]
Axon's Q3 Earnings Miss Estimates & Revenues Beat, 2025 View Up